跳至主要内容
临床试验/NCT07351812
NCT07351812招募中不适用

Evaluation of Two Treatment Modalities for Myogenous Temporomandibular Disorders: A Randomized Controlled Trial

Alexandria University0 个研究点目标入组 32 人开始时间: 2025年1月1日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
32

研究概览

简要总结

Temporomandibular disorder (TMD) is a common condition with multifactorial etiology, including trauma, emotional stress, parafunctional habits, and occlusal discrepancies. TMD may be classified as myogenous, involving the masticatory and cervical muscles, or arthrogenous, affecting the temporomandibular joint structures. Management approaches range from noninvasive to invasive methods. The intraoral stabilization appliance (SA) is a widely used noninvasive treatment, while the ear stent (ES) has recently been introduced for managing myogenous TMD.

Aim: This randomized clinical trial aims to compare the effectiveness of SA and ES in the management of myogenous TMD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Participants presenting with pain score grading at least 4 out of 10 on NRS.
  • Participants with fully dentate type I occlusion.
  • Patients experiencing no neurological disorders.

排除标准

  • Patients with arthrogenous TMJ will be excluded by Magnetic Resonance Imagining (MRI)
  • Patients who have clicking or crepitation.
  • Previous history of TMD treatment.
  • History of recent trauma.
  • The presence of systemic diseases (i.e., rheumatoid arthritis, osteoarthritis myologic or arthrological disease).
  • Vascular disease (migraine and hypertension).
  • Participants with uncontrolled systemic disease (diabetes), hematologic or neurologic disorders or inflammatory diseases.
  • Patients who: Underwent trigger point myofascial injection, intramuscular stimulation, or dry needling in the last six months or Underwent neck and/or shoulder surgery in the last year.

研究者

申办方类型
Other
责任方
Sponsor

相似试验